Cite
HARVARD Citation
Wang, H. et al. (2019). Altered expression of TIM‐3, LAG‐3, IDO, PD‐L1, and CTLA‐4 during nimotuzumab therapy correlates with responses and prognosis of oral squamous cell carcinoma patients. Journal of oral pathology & medicine. pp. 669-676. [Online].